Efficacy and Safety of a Pharmaco-Invasive Strategy Using Half-Dose Recombinant Human Prourokinase in Patients with ST-Segment Elevation Myocardial Infarction During Hospitalization.
Journal Information
Journal Title: Clin Appl Thromb Hemost
Detailed journal information not available.
Publication Details
Subject Category: Peripheral Vascular Disease
Available in Europe PMC: Yes
Available in PMC: Yes
PDF Available: No
Transparency Score
Transparency Indicators
Click on green indicators to view evidence textCore Indicators
"The authors declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article."
"Funding: The authors disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: This work was supported by the S&T Program of Chengde (No. 201804A013, 202109A019), the Medical Science Research Project of Hebei Province (No. 20200348), and the Hebei Province Master's Graduate Innovation Ability Training Funding Project (No. CXZZSS2023147)."
Additional Indicators
Assessment Info
Tool: rtransparent
OST Version: N/A
Last Updated: Aug 05, 2025